Health innovations address more complex biological disorders and are tailored to more targeted clienteles. Reimbursement models for these breakthrough innovations must evolve in order to benefit from their value to health, in a context where public payers’ and employers’ ability to pay is reaching its limits.

Project description

With several partners, Montréal InVivo wishes to analyze the various options for risk-sharing agreements based on the value of innovations that could be applied in Québec. Potentially, one or more projects will be set up to test them.



Interested in being part of this Project Committee ?

This Project Committee brings together multidisciplinary stakeholders including policy makers, health care professionals, patient support organizations, and companies from various sub-sectors.

Boîte à idées